tiprankstipranks
Holding ASHX?
Track your performance easily

ASHX Price & Analysis

ASHX ETF Chart & Stats

Xtrackers MSCI China A Inclusion Equity ETF (ASHX) Fund Flow Chart

No data currently available
Xtrackers MSCI China A Inclusion Equity ETF (ASHX) 1 year Net Flows: ―

ASHX ETF FAQ

What was ASHX’s price range in the past 12 months?
ASHX lowest ETF price was $16.42 and its highest was $22.68 in the past 12 months.
    What is the AUM of ASHX?
    As of Mar 12, 2024 The AUM of ASHX is 1.85M.
      Is ASHX overvalued?
      According to Wall Street analysts ASHX’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does ASHX pay dividends?
        ASHX pays a Annually dividend of $0.438 which represents an annual dividend yield of N/A. See more information on ASHX dividends here
          How many shares outstanding does ASHX have?
          ASHX has 250,001 shares outstanding.
            Which hedge fund is a major shareholder of ASHX?
            Currently, no hedge funds are holding shares in ASHX

            Top 10 Holdings

            Name
            Weight %
            CASH
            U.S. Dollar
            99.82%
            600518
            Kangmei Pharmaceutical Co., Ltd Class A
            0.18%
            Total100.00%

            ETF Description

            Xtrackers MSCI China A Inclusion Equity ETF

            ASHX tracks a market-cap-weighted index of Chinese A-share equities.
            Sector
            Size And Style
            Asset Class
            Equity
            Region
            Asia-Pacific
            Issuer
            Xtrackers
            Index Tracked
            MSCI China A Inclusion Index
            Ticker Symbol
            ASHX
            Popular ETFs
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis